Table 4.

PFS (progression free survival) according to KRAS mutation for the two different treatment arms

PFS	FUFOX	CAPOX	p-value (log rank)
	n = 105	n = 96	HR (95% CI)
All patients	8.2 months	6.4 months	0.18 0.81 (0.61-1.09)
WT	8.1months	6.4months	0.29
			0.82 (0.56-1.19)
Codon 12 mutation	9.9months	7.0months	0.12
			0.62 (0.33-1.14)
Codon 13 mutation	6.1months	13.3months	0.22
			2.52 (0.54-11.70)

PFS, HR hazard ratio by cox regression, CI confidence interval, WT wild type.